Aadi Bioscience, Inc.AADINASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-48.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-48.3%/yr
vs +45.9%/yr prior
Acceleration
-94.2pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 4.29% |
| 2023 | 49.80% |
| 2022 | 66.05% |
| 2021 | 31.06% |
| 2020 | 17.03% |
| 2019 | -28.17% |
| 2018 | 46.97% |
| 2017 | 6.86% |
| 2016 | -2.22% |
| 2015 | 0.00% |